Press Releases

Press Releases

August 30, 2018
Surface Oncology to Present at the Baird 2018 Global Healthcare Conference
August 14, 2018
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2018
July 30, 2018
FDA Grants Orphan Drug Designation to Surface Oncology’s SRF231 for the Treatment of Multiple Myeloma
June 21, 2018
Surface Oncology Recognized as one of the “Best Places to Work” by Boston Business Journal
June 12, 2018
Surface Oncology Announces Initiation of Phase I Clinical Trial of SRF373 / NZV930
June 11, 2018
Surface Oncology to be Added to the Russell 3000 Index and Russell 2000 Index
June 8, 2018
Surface Oncology to Present at Goldman Sachs 39th Annual Global Healthcare Conference
May 29, 2018
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2018
May 15, 2018
Surface Oncology to Present at 2018 UBS Global Healthcare Conference
April 23, 2018
Surface Oncology Announces Closing of $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
Displaying 1 - 10 of 14